SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
News & Events

Cetilar Villorba Corse at the Bologna Motor Show

Read more
Raw materials

News 2021: Sucrosomial® Berberine and Sucrosomial® Chromium

Read more
News & Events

Vitamina Veloce SiderAL ends the M32 2018 circuit in second place

Read more
Raw materials

UltraD3®: the first vitamin D3 with Sucrosomial® Technology

Read more
Muscles and joints

Diathermy and cetylated fatty acids (CFAs): a winning combination against muscle pain

Read more
News & Events

Cetilar® and Obiettivo 3 together towards Tokyo 2020

Read more
Iron deficiency

Sucrosomial Iron quoted in Expert Opinion on Pharmacotherapy

Read more
News & Events

Interest and positive feedback also in Parma for We Are Cetilar

Read more
Raw materials

Alesco on a visit to Marigot Ltd’s Icelandic plant

Read more
Iron deficiency

Iron Deficiency in Oncology: A Still Overlooked Clinical Challenge

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
News & Events

PharmaNutra participates in the Italian Mid Cap Conference 2021

Read more
News & Events

Cetilar Villorba Corse at the start of the 24 Hours of Le Mans 2018

Read more
Raw materials

UltraChrome®: Sucrosomial® Chromium that supports the metabolism and glycaemic control

Read more
Raw materials

SiderAL® r.m is among the finalists at the Nutraingredients Awards 2016

Read more